Kevin Caliendo
Stock Analyst at UBS
(4.32)
# 416
Out of 4,711 analysts
160
Total ratings
68.42%
Success rate
10.28%
Average return
Main Sectors:
Stocks Rated by Kevin Caliendo
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
XRAY DENTSPLY SIRONA | Maintains: Buy | $35 → $27 | $18.70 | +44.39% | 9 | Dec 3, 2024 | |
CVS CVS Health | Maintains: Neutral | $60 → $62 | $44.36 | +39.77% | 6 | Nov 7, 2024 | |
COR Cencora | Maintains: Buy | $275 → $285 | $227.69 | +25.17% | 1 | Nov 7, 2024 | |
OMI Owens & Minor | Maintains: Buy | $28 → $25 | $12.52 | +99.68% | 4 | Nov 5, 2024 | |
CAH Cardinal Health | Maintains: Buy | $134 → $139 | $118.28 | +17.52% | 15 | Nov 4, 2024 | |
ALHC Alignment Healthcare | Maintains: Neutral | $9 → $12 | $10.61 | +13.10% | 6 | Oct 30, 2024 | |
DGX Quest Diagnostics | Maintains: Neutral | $165 → $166 | $153.10 | +8.43% | 12 | Oct 23, 2024 | |
WBA Walgreens Boots Alliance | Maintains: Neutral | $9 → $10 | $9.55 | +4.71% | 14 | Oct 17, 2024 | |
UNH UnitedHealth Group | Maintains: Buy | $680 → $650 | $500.13 | +29.97% | 11 | Oct 16, 2024 | |
HUM Humana | Maintains: Neutral | $380 → $250 | $247.10 | +1.17% | 6 | Oct 4, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $7.5 | $7.29 | +2.88% | 3 | Aug 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $8.5 | $4.44 | +91.44% | 3 | Aug 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $75 → $72 | $69.82 | +3.12% | 4 | Aug 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $260 → $270 | $228.61 | +18.11% | 1 | Aug 2, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $30 → $12 | $7.87 | +52.48% | 2 | May 23, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $620 → $630 | $579.74 | +8.67% | 13 | May 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $280 → $320 | $211.06 | +51.62% | 17 | Apr 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $385 → $400 | $276.92 | +44.45% | 10 | Mar 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $26 | $18.70 | +39.04% | 1 | Jan 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $350 → $380 | $294.73 | +28.93% | 2 | Dec 21, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $79 | $59.58 | +32.59% | 2 | Dec 21, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $46 | $11.41 | +303.16% | 1 | Oct 16, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $29 → $26 | $21.76 | +19.49% | 1 | Aug 23, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $610 → $575 | $365.96 | +57.12% | 1 | Jul 13, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $185 → $180 | $144.47 | +24.59% | 7 | Jul 21, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $130 → $72 | $9.44 | +662.71% | 4 | Mar 8, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $11 | $22.09 | -50.20% | 4 | May 4, 2021 |
DENTSPLY SIRONA
Dec 3, 2024
Maintains: Buy
Price Target: $35 → $27
Current: $18.70
Upside: +44.39%
CVS Health
Nov 7, 2024
Maintains: Neutral
Price Target: $60 → $62
Current: $44.36
Upside: +39.77%
Cencora
Nov 7, 2024
Maintains: Buy
Price Target: $275 → $285
Current: $227.69
Upside: +25.17%
Owens & Minor
Nov 5, 2024
Maintains: Buy
Price Target: $28 → $25
Current: $12.52
Upside: +99.68%
Cardinal Health
Nov 4, 2024
Maintains: Buy
Price Target: $134 → $139
Current: $118.28
Upside: +17.52%
Alignment Healthcare
Oct 30, 2024
Maintains: Neutral
Price Target: $9 → $12
Current: $10.61
Upside: +13.10%
Quest Diagnostics
Oct 23, 2024
Maintains: Neutral
Price Target: $165 → $166
Current: $153.10
Upside: +8.43%
Walgreens Boots Alliance
Oct 17, 2024
Maintains: Neutral
Price Target: $9 → $10
Current: $9.55
Upside: +4.71%
UnitedHealth Group
Oct 16, 2024
Maintains: Buy
Price Target: $680 → $650
Current: $500.13
Upside: +29.97%
Humana
Oct 4, 2024
Maintains: Neutral
Price Target: $380 → $250
Current: $247.10
Upside: +1.17%
Aug 15, 2024
Maintains: Neutral
Price Target: $9 → $7.5
Current: $7.29
Upside: +2.88%
Aug 9, 2024
Maintains: Neutral
Price Target: $9 → $8.5
Current: $4.44
Upside: +91.44%
Aug 7, 2024
Maintains: Neutral
Price Target: $75 → $72
Current: $69.82
Upside: +3.12%
Aug 2, 2024
Maintains: Buy
Price Target: $260 → $270
Current: $228.61
Upside: +18.11%
May 23, 2024
Maintains: Neutral
Price Target: $30 → $12
Current: $7.87
Upside: +52.48%
May 8, 2024
Maintains: Buy
Price Target: $620 → $630
Current: $579.74
Upside: +8.67%
Apr 15, 2024
Maintains: Neutral
Price Target: $280 → $320
Current: $211.06
Upside: +51.62%
Mar 8, 2024
Maintains: Buy
Price Target: $385 → $400
Current: $276.92
Upside: +44.45%
Jan 5, 2024
Initiates: Neutral
Price Target: $26
Current: $18.70
Upside: +39.04%
Dec 21, 2023
Maintains: Neutral
Price Target: $350 → $380
Current: $294.73
Upside: +28.93%
Dec 21, 2023
Maintains: Neutral
Price Target: $72 → $79
Current: $59.58
Upside: +32.59%
Oct 16, 2023
Initiates: Buy
Price Target: $46
Current: $11.41
Upside: +303.16%
Aug 23, 2023
Maintains: Neutral
Price Target: $29 → $26
Current: $21.76
Upside: +19.49%
Jul 13, 2023
Maintains: Buy
Price Target: $610 → $575
Current: $365.96
Upside: +57.12%
Jul 21, 2022
Maintains: Neutral
Price Target: $185 → $180
Current: $144.47
Upside: +24.59%
Mar 8, 2022
Maintains: Neutral
Price Target: $130 → $72
Current: $9.44
Upside: +662.71%
May 4, 2021
Downgrades: Neutral
Price Target: $15 → $11
Current: $22.09
Upside: -50.20%